Constipation News and Research

Latest Constipation News and Research

Abstral transmucosal tablets receive FDA approval, may help manage pain in cancer patients

Abstral transmucosal tablets receive FDA approval, may help manage pain in cancer patients

9 Jan 2011
Synergy's plecanatide Phase II/III trial to begin in second quarter 2011

Synergy's plecanatide Phase II/III trial to begin in second quarter 2011

7 Jan 2011
Sucampo, Takeda initiate dosing in third lubiprostone phase 3 trial for opioid-induced bowel dysfunction

Sucampo, Takeda initiate dosing in third lubiprostone phase 3 trial for opioid-induced bowel dysfunction

7 Jan 2011
Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms

Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms

6 Jan 2011
Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

6 Jan 2011
Study: Antibiotics can provide long-lasting relief to patients with irritable bowel syndrome

Study: Antibiotics can provide long-lasting relief to patients with irritable bowel syndrome

6 Jan 2011
Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

5 Jan 2011
Fruit fly faeces provides answers to pregnant women's bloating and constipation

Fruit fly faeces provides answers to pregnant women's bloating and constipation

5 Jan 2011
Study suggests new experimental drug is better than standard morphine

Study suggests new experimental drug is better than standard morphine

5 Jan 2011
Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

22 Dec 2010
Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

17 Dec 2010
Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

14 Dec 2010
Nektar reports positive results from NKTR-102 Phase 2 study in metastatic breast cancer at CTRC-AACR SABCS

Nektar reports positive results from NKTR-102 Phase 2 study in metastatic breast cancer at CTRC-AACR SABCS

14 Dec 2010
School children who dislike fruits and vegetables are more likely to develop functional constipation

School children who dislike fruits and vegetables are more likely to develop functional constipation

13 Dec 2010
Sunovion reports results of Latuda third phase 3 worldwide clinical trial for schizophrenia

Sunovion reports results of Latuda third phase 3 worldwide clinical trial for schizophrenia

9 Dec 2010
Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

8 Dec 2010
Positive interim results from elotuzumab Phase 1b/2 study in relapsed multiple myeloma

Positive interim results from elotuzumab Phase 1b/2 study in relapsed multiple myeloma

7 Dec 2010
Data from comparative REVLIMID study in multiple myeloma presented at 52nd ASH

Data from comparative REVLIMID study in multiple myeloma presented at 52nd ASH

7 Dec 2010
Positive results from PROCHIEVE 8% vaginal progesterone gel Phase III trial to reduce preterm birth risk

Positive results from PROCHIEVE 8% vaginal progesterone gel Phase III trial to reduce preterm birth risk

7 Dec 2010
Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

6 Dec 2010

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback